title: Regulation of the expression and activity by progestins of a member of the SOX gene family of transcriptional modulators.
abstract: The mammalian testis-determining gene Sry and the related Sox genes define a family of transcriptional regulators widely expressed during embryogenesis. Tightly controlled temporal profiles of expression are a feature of the Sox gene family and may be required for initiation of a cascade of gene expression, yet the molecular mechanisms that control Sox gene expression are unknown. We now show that human SOX4 is expressed in the normal breast and in breast cancer cells. In these cells SOX4 is a progesterone-regulated gene, the expression of which is increased by progestins, leading to a marked increase in SOX-mediated transcriptional activity. Treatment of T-47D breast cancer cells with the synthetic progestin ORG 2058 directly increased SOX4 transcription, resulting in a 4-fold increase in SOX4 mRNA levels within 4 h of treatment. No effect of ORG 2058 was noted on other SOX genes measured, nor were other hormone-regulated HMG box proteins detected in this system, suggesting that the observed ability of progestin to increase SOX mRNA expression was confined to SOX4. The increase in SOX4 transcription was reflected in increased SOX4 protein expression, as progestin treatment of T-47D cells transfected with a SOX-responsive reporter resulted in a marked increase in reporter gene expression. Progesterone is essential for normal development and differentiation of the female reproductive system, plays an essential role in regulating growth and differentiation of the mammary gland and is required for opposing the proliferative effects of estrogen in specific cell types. The detection of SOX4 expression in the normal and malignant breast and the demonstration that SOX4 expression is under progesterone control suggests that changes in SOX4 gene expression may play a role in commitment to the differentiated phenotype in the normal and malignant mammary gland.
authors.affiliation: Westmead Institute for Cancer Research, University of Sydney, Westmead Hospital, Westmead, New South Wales 2145, Australia.
authors.forename: J D
authors.initials: JD
authors.lastname: Graham
authors.forename: S M
authors.initials: SM
authors.lastname: Hunt
authors.forename: N
authors.initials: N
authors.lastname: Tran
authors.forename: C L
authors.initials: CL
authors.lastname: Clarke
mesh_terms: D001483:Base Sequence; D001940:Breast / Q000166:cytology / Q000378:metabolism; D001943:Breast Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D002460:Cell Line; D017931:DNA Primers; D005786:Gene Expression Regulation / Q000187:drug effects*; D006609:High Mobility Group Proteins / Q000235:genetics*; D006801:Humans; D016133:Polymerase Chain Reaction; D011372:Progestins / Q000494:pharmacology*; D012333:RNA, Messenger / Q000235:genetics; D055751:SOXC Transcription Factors; D015534:Trans-Activators / Q000235:genetics*; D014158:Transcription, Genetic / Q000187:drug effects; D014407:Tumor Cells, Cultured
chemical_list: D017931:DNA Primers; D006609:High Mobility Group Proteins; D011372:Progestins; D012333:RNA, Messenger; C083431:SOX4 protein, human; D055751:SOXC Transcription Factors; D015534:Trans-Activators